Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 117

1.

Expression Profiling Identifies the Noncoding Processed Transcript of HNRNPU with Proliferative Properties in Pancreatic Ductal Adenocarcinoma.

Sutaria DS, Jiang J, Azevedo-Pouly ACP, Lee EJ, Lerner MR, Brackett DJ, Vandesompele J, Mestdagh P, Schmittgen TD.

Noncoding RNA. 2017 Aug 25;3(3). pii: E24. doi: 10.3390/ncrna3030024.

2.

Serum Monitoring and Phenotype Identification of Stage I Non-Small Cell Lung Cancer Patients.

Hocker JR, Deb SJ, Li M, Lerner MR, Lightfoot SA, Quillet AA, Hanas RJ, Reinersman M, Thompson JL, Vu NT, Kupiec TC, Brackett DJ, Peyton MD, Dubinett SM, Burkhart HM, Postier RG, Hanas JS.

Cancer Invest. 2017 Oct 21;35(9):573-585. doi: 10.1080/07357907.2017.1373120. Epub 2017 Sep 26.

PMID:
28949774
3.

Post-blast treatment with Nociceptin/Orphanin FQ peptide (NOP) receptor antagonist reduces brain injury-induced hypoxia and signaling proteins in vestibulomotor-related brain regions.

Awwad HO, Durand CD, Gonzalez LP, Tompkins P, Zhang Y, Lerner MR, Brackett DJ, Sherry DM, Awasthi V, Standifer KM.

Behav Brain Res. 2018 Mar 15;340:183-194. doi: 10.1016/j.bbr.2016.10.041. Epub 2016 Oct 25.

PMID:
27793733
4.

Globally increased ultraconserved noncoding RNA expression in pancreatic adenocarcinoma.

Jiang J, Azevedo-Pouly AC, Redis RS, Lee EJ, Gusev Y, Allard D, Sutaria DS, Badawi M, Elgamal OA, Lerner MR, Brackett DJ, Calin GA, Schmittgen TD.

Oncotarget. 2016 Aug 16;7(33):53165-53177. doi: 10.18632/oncotarget.10242.

5.

Blast Overpressure Waves Induce Transient Anxiety and Regional Changes in Cerebral Glucose Metabolism and Delayed Hyperarousal in Rats.

Awwad HO, Gonzalez LP, Tompkins P, Lerner M, Brackett DJ, Awasthi V, Standifer KM.

Front Neurol. 2015 Jun 17;6:132. doi: 10.3389/fneur.2015.00132. eCollection 2015.

6.

Discriminating patients with early-stage pancreatic cancer or chronic pancreatitis using serum electrospray mass profiling.

Hocker JR, Postier RG, Li M, Lerner MR, Lightfoot SA, Peyton MD, Deb SJ, Baker CM, Williams TL, Hanas RJ, Stowell DE, Lander TJ, Brackett DJ, Hanas JS.

Cancer Lett. 2015 Apr 10;359(2):314-24. doi: 10.1016/j.canlet.2015.01.035. Epub 2015 Jan 28.

7.

Oncolytic potential of a novel KGFR tyrosine kinase inhibitor using a KGFR-selective breast cancer xenograft model.

Kesinger JW, Mehta M, Lerner MR, Brackett DJ, Brueggemeier RW, Li PK, Pento JT.

Anticancer Res. 2015 Jan;35(1):47-52.

PMID:
25550534
8.

Distinguishing patients with stage I lung cancer versus control individuals using serum mass profiling.

Hanas JS, Peyton MD, Lerner MR, Lightfoot SA, Deb SJ, Hanas RJ, Vu NT, Kupiec TC, Stowell DE, Brackett DJ, Dubinett SM, Hocker JR.

Cancer Invest. 2014 May;32(4):136-43. doi: 10.3109/07357907.2014.883528. Epub 2014 Feb 28.

PMID:
24579933
9.

Brain injury: neuro-inflammation, cognitive deficit, and magnetic resonance imaging in a model of blast induced traumatic brain injury.

Tompkins P, Tesiram Y, Lerner M, Gonzalez LP, Lightfoot S, Rabb CH, Brackett DJ.

J Neurotrauma. 2013 Nov 15;30(22):1888-97. doi: 10.1089/neu.2012.2674. Epub 2013 Sep 17.

PMID:
23777197
10.

Silica-based branched hollow microfibers as a biomimetic extracellular matrix for promoting tumor cell growth in vitro and in vivo.

Qiu P, Qu X, Brackett DJ, Lerner MR, Li D, Mao C.

Adv Mater. 2013 May 7;25(17):2492-6. doi: 10.1002/adma.201204472. Epub 2013 Mar 1.

11.

Utility of nuclear magnetic resonance spectroscopy for pancreatic cancer studies.

Tesiram YA, Lerner M, Stewart C, Njoku C, Brackett DJ.

Pancreas. 2012 Apr;41(3):474-80. doi: 10.1097/MPA.0b013e31822a708c.

PMID:
22422139
12.

Distinguishing non-small cell lung adenocarcinoma patients from squamous cell carcinoma patients and control individuals using serum profiling.

Hocker JR, Peyton MD, Lerner MR, Lightfoot SA, Hanas RJ, Brackett DJ, Hanas JS.

Cancer Invest. 2012 Feb;30(2):180-8. doi: 10.3109/07357907.2011.633294. Epub 2011 Dec 7.

PMID:
22149138
13.

Serum profiling to distinguish early- and late-stage ovarian cancer patients from disease-free individuals.

Hocker JR, Bishop EA, Lightfoot SA, Lerner MR, Peyton MD, Brackett DJ, Hanas RJ, McMeekin DS, Walker JL, Hanas JS.

Cancer Invest. 2012 Feb;30(2):189-97. doi: 10.3109/07357907.2011.636115. Epub 2011 Dec 7.

PMID:
22149058
14.

Serum discrimination of early-stage lung cancer patients using electrospray-ionization mass spectrometry.

Hocker JR, Peyton MD, Lerner MR, Mitchell SL, Lightfoot SA, Lander TJ, Bates-Albers LM, Vu NT, Hanas RJ, Kupiec TC, Brackett DJ, Hanas JS.

Lung Cancer. 2011 Nov;74(2):206-11. doi: 10.1016/j.lungcan.2011.03.014. Epub 2011 May 6.

PMID:
21529985
15.

miR-132 and miR-212 are increased in pancreatic cancer and target the retinoblastoma tumor suppressor.

Park JK, Henry JC, Jiang J, Esau C, Gusev Y, Lerner MR, Postier RG, Brackett DJ, Schmittgen TD.

Biochem Biophys Res Commun. 2011 Mar 25;406(4):518-23. doi: 10.1016/j.bbrc.2011.02.065. Epub 2011 Feb 15.

16.

DCAMKL-1 regulates epithelial-mesenchymal transition in human pancreatic cells through a miR-200a-dependent mechanism.

Sureban SM, May R, Lightfoot SA, Hoskins AB, Lerner M, Brackett DJ, Postier RG, Ramanujam R, Mohammed A, Rao CV, Wyche JH, Anant S, Houchen CW.

Cancer Res. 2011 Mar 15;71(6):2328-38. doi: 10.1158/0008-5472.CAN-10-2738. Epub 2011 Feb 1.

17.

Distinguishing early-stage pancreatic cancer patients from disease-free individuals using serum profiling.

Hocker JR, Lerner MR, Mitchell SL, Lightfoot SA, Lander TJ, Quillet AA, Hanas RJ, Peyton MD, Postier RG, Brackett DJ, Hanas JS.

Cancer Invest. 2011 Feb;29(2):173-9. doi: 10.3109/07357907.2010.543214.

PMID:
21261478
18.

Influence of novel KGFR tyrosine kinase inhibitors on KGF-mediated proliferation of breast cancer.

Mehta M, Kesinger JW, Zang XP, Lerner ML, Brackett DJ, Brueggemeier RW, Li PK, Pento JT.

Anticancer Res. 2010 Dec;30(12):4883-9.

PMID:
21187466
19.

Identification of a novel putative pancreatic stem/progenitor cell marker DCAMKL-1 in normal mouse pancreas.

May R, Sureban SM, Lightfoot SA, Hoskins AB, Brackett DJ, Postier RG, Ramanujam R, Rao CV, Wyche JH, Anant S, Houchen CW.

Am J Physiol Gastrointest Liver Physiol. 2010 Aug;299(2):G303-10. doi: 10.1152/ajpgi.00146.2010. Epub 2010 Jun 3.

20.

Molecular MRI assessment of vascular endothelial growth factor receptor-2 in rat C6 gliomas.

He T, Smith N, Saunders D, Doblas S, Watanabe Y, Hoyle J, Silasi-Mansat R, Lupu F, Lerner M, Brackett DJ, Towner RA.

J Cell Mol Med. 2011 Apr;15(4):837-49. doi: 10.1111/j.1582-4934.2010.01091.x.

21.

Systemic molecular and cellular changes induced in rats upon inhalation of JP-8 petroleum fuel vapor.

Hanas JS, Bruce Briggs G, Lerner MR, Lightfoot SA, Larabee JL, Karsies TJ, Epstein RB, Hanas RJ, Brackett DJ, Hocker JR.

Toxicol Mech Methods. 2010 May;20(4):204-12. doi: 10.3109/15376511003681009.

PMID:
20233090
22.

Sepsis induces extensive autophagic vacuolization in hepatocytes: a clinical and laboratory-based study.

Watanabe E, Muenzer JT, Hawkins WG, Davis CG, Dixon DJ, McDunn JE, Brackett DJ, Lerner MR, Swanson PE, Hotchkiss RS.

Lab Invest. 2009 May;89(5):549-61. doi: 10.1038/labinvest.2009.8. Epub 2009 Feb 2.

23.

Dichotomous metabolism of Enterococcus faecalis induced by haematin starvation modulates colonic gene expression.

Allen TD, Moore DR, Wang X, Casu V, May R, Lerner MR, Houchen C, Brackett DJ, Huycke MM.

J Med Microbiol. 2008 Oct;57(Pt 10):1193-204. doi: 10.1099/jmm.0.47798-0.

24.

Microarray analysis of choroid/RPE gene expression in marmoset eyes undergoing changes in ocular growth and refraction.

Shelton L, Troilo D, Lerner MR, Gusev Y, Brackett DJ, Rada JS.

Mol Vis. 2008 Aug 11;14:1465-79.

25.

Innate responses to systemic infection by intracellular bacteria trigger recruitment of Ly-6Chigh monocytes to the brain.

Drevets DA, Schawang JE, Dillon MJ, Lerner MR, Bronze MS, Brackett DJ.

J Immunol. 2008 Jul 1;181(1):529-36.

26.

Dried plum polyphenols inhibit osteoclastogenesis by downregulating NFATc1 and inflammatory mediators.

Bu SY, Lerner M, Stoecker BJ, Boldrin E, Brackett DJ, Lucas EA, Smith BJ.

Calcif Tissue Int. 2008 Jun;82(6):475-88. doi: 10.1007/s00223-008-9139-0.

PMID:
18509698
27.

Translation regulatory factor RBM3 is a proto-oncogene that prevents mitotic catastrophe.

Sureban SM, Ramalingam S, Natarajan G, May R, Subramaniam D, Bishnupuri KS, Morrison AR, Dieckgraefe BK, Brackett DJ, Postier RG, Houchen CW, Anant S.

Oncogene. 2008 Jul 31;27(33):4544-56. doi: 10.1038/onc.2008.97. Epub 2008 Apr 21.

28.

Induction of cardiovascular pathology in a novel model of low-grade chronic inflammation.

Smith BJ, Lightfoot SA, Lerner MR, Denson KD, Morgan DL, Hanas JS, Bronze MS, Postier RG, Brackett DJ.

Cardiovasc Pathol. 2009 Jan-Feb;18(1):1-10. doi: 10.1016/j.carpath.2007.07.011. Epub 2007 Oct 24.

PMID:
18402801
29.

Development of keratinocyte growth factor receptor tyrosine kinase inhibitors for the treatment of cancer.

Hackett J, Xiao Z, Zang XP, Lerner ML, Brackett DJ, Brueggemeier RW, Li PK, Pento JT.

Anticancer Res. 2007 Nov-Dec;27(6B):3801-6.

30.

Association of MicroRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival.

Jiang J, Gusev Y, Aderca I, Mettler TA, Nagorney DM, Brackett DJ, Roberts LR, Schmittgen TD.

Clin Cancer Res. 2008 Jan 15;14(2):419-27. doi: 10.1158/1078-0432.CCR-07-0523.

31.

Biomarker identification in human pancreatic cancer sera.

Hanas JS, Hocker JR, Cheung JY, Larabee JL, Lerner MR, Lightfoot SA, Morgan DL, Denson KD, Prejeant KC, Gusev Y, Smith BJ, Hanas RJ, Postier RG, Brackett DJ.

Pancreas. 2008 Jan;36(1):61-9. doi: 10.1097/mpa.0b013e3180d0a738.

PMID:
18192883
32.

Systematic evaluation of microRNA processing patterns in tissues, cell lines, and tumors.

Lee EJ, Baek M, Gusev Y, Brackett DJ, Nuovo GJ, Schmittgen TD.

RNA. 2008 Jan;14(1):35-42. Epub 2007 Nov 19.

33.

MicroRNA expression profiling in cancer from a bioinformatics prospective.

Gusev Y, Brackett DJ.

Expert Rev Mol Diagn. 2007 Nov;7(6):787-92. Review.

PMID:
18020908
34.

Soy isoflavones avert chronic inflammation-induced bone loss and vascular disease.

Droke EA, Hager KA, Lerner MR, Lightfoot SA, Stoecker BJ, Brackett DJ, Smith BJ.

J Inflamm (Lond). 2007 Sep 7;4:17. doi: 10.1186/1476-9255-4-17.

35.

Comparison of dried plum supplementation and intermittent PTH in restoring bone in osteopenic orchidectomized rats.

Bu SY, Lucas EA, Franklin M, Marlow D, Brackett DJ, Boldrin EA, Devareddy L, Arjmandi BH, Smith BJ.

Osteoporos Int. 2007 Jul;18(7):931-42. Epub 2007 Feb 15.

PMID:
17554580
36.

Expression profiling identifies microRNA signature in pancreatic cancer.

Lee EJ, Gusev Y, Jiang J, Nuovo GJ, Lerner MR, Frankel WL, Morgan DL, Postier RG, Brackett DJ, Schmittgen TD.

Int J Cancer. 2007 Mar 1;120(5):1046-54.

37.

A Comparison of KGF Receptor Expression in Various Types of Human Cancer.

Zang XP, Lerner MR, Bahr SJ, Brackett DJ, Pento JT.

Cancer Genomics Proteomics. 2006 Nov-Dec;3(6):369-372. Epub 2006 Nov 1.

38.

Dried plum prevents bone loss in a male osteoporosis model via IGF-I and the RANK pathway.

Franklin M, Bu SY, Lerner MR, Lancaster EA, Bellmer D, Marlow D, Lightfoot SA, Arjmandi BH, Brackett DJ, Lucas EA, Smith BJ.

Bone. 2006 Dec;39(6):1331-42. Epub 2006 Aug 4.

PMID:
16890505
39.

Targeting a methioninase-containing fusion protein to breast cancer urokinase receptors inhibits growth and migration.

Zang XP, Palwai NR, Lerner MR, Brackett DJ, Pento JT, Harrison RG.

Anticancer Res. 2006 May-Jun;26(3A):1745-51.

40.

Stress induced in heart and other tissues by rat dermal exposure to JP-8 fuel.

Larabee JL, Hocker JR, Lerner MR, Lightfoot SA, Cheung JY, Brackett DJ, Gallucci RM, Hanas JS.

Cell Biol Toxicol. 2005 Sep-Nov;21(5-6):233-46.

PMID:
16323059
41.

[1,2-13C2]-D-glucose profiles of the serum, liver, pancreas, and DMBA-induced pancreatic tumors of rats.

Boros LG, Lerner MR, Morgan DL, Taylor SL, Smith BJ, Postier RG, Brackett DJ.

Pancreas. 2005 Nov;31(4):337-43.

PMID:
16258367
42.

Systemic bone loss and induction of coronary vessel disease in a rat model of chronic inflammation.

Smith BJ, Lerner MR, Bu SY, Lucas EA, Hanas JS, Lightfoot SA, Postier RG, Bronze MS, Brackett DJ.

Bone. 2006 Mar;38(3):378-86. Epub 2005 Oct 26.

PMID:
16256450
43.

Diverse gene expression pattern during 5-fluorouridine-induced apoptosis.

Schmittgen TD, Gissel KA, Zakrajsek BA, Lawrence BP, Liu Q, Jupe ER, Lerner MR, Do SV, Brackett DJ.

Int J Oncol. 2005 Aug;27(2):297-306.

PMID:
16010409
44.

Cocaine up-regulates Fra-2 and sigma-1 receptor gene and protein expression in brain regions involved in addiction and reward.

Liu Y, Chen GD, Lerner MR, Brackett DJ, Matsumoto RR.

J Pharmacol Exp Ther. 2005 Aug;314(2):770-9. Epub 2005 May 5.

PMID:
15879001
45.

Vitamin E provides protection for bone in mature hindlimb unloaded male rats.

Smith BJ, Lucas EA, Turner RT, Evans GL, Lerner MR, Brackett DJ, Stoecker BJ, Arjmandi BH.

Calcif Tissue Int. 2005 Apr;76(4):272-9. Epub 2004 Mar 8.

PMID:
15742232
46.
47.

Expression of prohibitin 3' untranslated region suppressor RNA alters morphology and inhibits motility of breast cancer cells.

Manjeshwar S, Lerner MR, Zang XP, Branam DE, Pento JT, Lane MM, Lightfoot SA, Brackett DJ, Jupe ER.

J Mol Histol. 2004 Aug;35(6):639-46.

PMID:
15614618
48.

Keratinocyte Growth Factor-Mediated Pattern of Gene Expression in Breast Cancer Cells.

Zang XP, Lerner ML, DO SV, Brackett DJ, Pento JT.

Cancer Genomics Proteomics. 2004 Jul-Aug;1(4):339-344. Epub 2004 Jul 1.

49.

Antisense KGFR oligonucleotide inhibition of KGF-induced motility in breast cancer cells.

Zang XP, Lerner MR, Dunn ST, Brackett DJ, Pento JT.

Anticancer Res. 2003 Nov-Dec;23(6C):4913-9.

PMID:
14981945
50.

Metabolic biomarker and kinase drug target discovery in cancer using stable isotope-based dynamic metabolic profiling (SIDMAP).

Boros LG, Brackett DJ, Harrigan GG.

Curr Cancer Drug Targets. 2003 Dec;3(6):445-53. Review.

PMID:
14683502

Supplemental Content

Loading ...
Support Center